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Letters to the Editor
Letters to the Editor
Managerial Epidemiology Is
the Best Evaluation Tool for
Our New Health Care System
To the Editor: Given that the
overarching goal of health care reform
is to improve the health of our
population, the focus of health services
management (as well as clinical
practice) should be on the health of
the populations they serve and not
solely the fiscal health of their
institutions.1 For this reason, I maintain
that the science of public health
management, namely managerial
epidemiology, is the evaluation tool of
choice. It is that branch of
epidemiology that utilizes the
traditional quantitative and causal
reasoning methods taught in medical
schools. It also incorporates the
business aspects of health care that
monitor demand, delivery, clinical
outcome measurement, resource
allocation, strategic analysis, program
planning, and managed care. With 30
million more people in our health care
system, we need to refine further our
ability to provide equitable care while
containing costs and ultimately
reducing the demand for health care.
Managerial epidemiology is “the
scientific basis for any health system
reform”2 and is the science that must
pervade professional preparation in
both clinical and management
practice.
Our health care leaders and providers
need to be change agents in aligning
social and economic objectives so that
the improvement of population health
is the prime metric of success.
Integrating public health and personal
health care policy and services is the
silent and significant challenge.
Distinctively, managerial epidemiology
can measure the effectiveness of our
newly revised system. It can tell us
whether our reformed health care
system is any more effective in
improving the human condition. It is
the metric to assess the implications of
health care reform.
Rosemary M. Caron, PhD, MPH
Associate professor, University of New Hampshire,
Durham, New Hampshire, and chair-elect,
Association for University Programs in Health
Administration, Public Health Faculty Network;
rosemary.caron@unh.edu.
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Time to Clarify Guidelines for
Researchers and IRBs in
Medical Education Research
To the Editor: I applaud the
requirement announced by the editor
of Academic Medicine that reports of
studies submitted to the journal must
include details of ethical approval for the
research or, if the author does not have
access to a formal approval process,
information about the treatment of the
study’s human participants.1
In addition to the editor’s five reasons
for this requirement, I would add
another one: that students or residents
or even faculty recruited for educational
research studies are potentially
vulnerable to coercion to participate, loss
of privacy, or adverse actions.
It is not always easy to balance this
potential vulnerability of students,
residents, and faculty against existing
regulations and researchers’ goals in
recruiting subjects. Medical education
research may be exempt from
institutional review board (IRB) approval,
under the provisions of Subpart A,
Section 46.101 of the Federal Code of
Regulations regarding “research
conducted in established or commonly
accepted educational settings, involving
normal educational practices.”2
However, there appears to be
considerable variation in the way this
provision is interpreted and implemented
by different IRBs, as previously reported
in Academic Medicine.3–5
I hope the journal will publish more
discussion about the ethics of medical
education research. It’s time to clarify
the guidelines for researchers and IRBs.
Nicholas H. Fiebach, MD
Professor of clinical medicine and vice chair for
graduate and continuing medical education,
Department of Medicine, Columbia University
College of Physicians and Surgeons, New York, New
York; nhf2101@columbia.edu.
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A Framework for Designing
Training in Medical Advocacy
To the Editor: In their January
article, Earnest et al1 adeptly highlight
the need for the creation and delivery
of more formalized training in medical
advocacy. Toward this worthwhile
goal, we offer the following
framework of learning objectives,
derived from our experiences teaching
advocacy to medical students at the
Boston University School of Medicine
(BUSM). Our program is student-led in
conjunction with mentorship from
faculty at BUSM and the professional
advocates at the National Center for
Medical–Legal Partnership.2 Over the
past six years, it has evolved from a
single elective to a multiyear
curriculum with both clinical and
preclinical components. The learning
objectives we present here arose from
this continuing curricular development
and might provide a starting point for
other institutions interested in
designing formalized training in
medical advocacy for medical students.
To skillfully engage in the types of
advocacy that Earnest et al describe,
medical students need to develop skills
in advocacy theory, execution, and
communication. Formal study of the
theory of advocacy helps medical
students define their roles as advocates
and explore their positions along the
spectrum of physician advocacy.
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Experience in executing defined
advocacy projects removes potentially
formidable barriers to using advocacy
in clinical settings by honing skills and
developing both competence and
confidence. Finally, training in
communication enables medical
students to translate clinical
observations for wider audiences and
to teach advocacy to other medical
professionals.
Learning objectives dealing with
advocacy theory might include (1)
formally identifying and distinguishing
between the roles that physicians
must, should, and could perform
within the spectrum of physician
advocacy, and (2) developing a
rigorous understanding of the social
determinants of health.
Learning objectives centered on
advocacy execution might include
practice in distilling clinical
observations from multiple patients
into a well-defined issue in need of
advocacy, then engaging in a small-
scale advocacy project. Examples
include writing an op-ed for a local
paper or developing an “advocacy
code card” that clerks can use to help
their patients receive benefits like
Womens, Infants, and Children
nutrition vouchers.
Learning objectives dealing with
advocacy communication might
include completing a press release, oral
presentation, or lecture for a
nonmedical community, or presenting
a patient whose clinical course is
complicated by socioeconomic issues
to a group of medical peers.
Daniel A. Dworkis
MD–PhD candidate, Department of Molecular
Medicine, Boston University School of Medicine,
Boston, Massachusetts; ddworkis@bu.edu.
MaryAnn B. Wilbur
MD–MPH candidate, Boston University School of
Medicine, Boston, Massachusetts.
Megan T. Sandel, MD, MPH
National medical director, National Center for
Medical–Legal Partnership, Boston, Massachusetts.
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In Reply: We applaud the efforts
described by Dworkis et al at BUSM in
developing a longitudinal educational
experience in advocacy. They describe
a useful framework in which to plan
and implement a curriculum where
advocacy competencies are developed
as a part of physician practice and
professionalism. Their program and
our LEADS (Leadership Education
Advocacy Development Scholarship)
program at the University of Colorado,
as well as a handful of other programs
across the country, represent a
growing interest in this type of
training. The success of these
emerging courses demonstrates the
feasibility of implementing such
curricula.
In our article, we highlight several
examples of physicians incorporating
advocacy into their professional roles.
Each example emphasizes an
advocacy-related competency or skill.
We assert that these competencies
need to be incorporated into medical
training so that every physician
achieves some basic level of
competence in advocacy. Reaching this
goal would require that advocacy
become an accepted component of
professionalism and that licensing and
accrediting bodies recognize it as such.
Only through these means will we
move beyond our current status of
professional aspiration without
commensurate professional action. We
see these curricular innovations as a
critical step in the process toward
institutionalizing these values and
developing the skills. Given the
variation among current programs, an
important next step is to promote
collaboration and ultimately consensus
on a common set of competencies and
learning objectives. Achieving this goal
will require new funding sources and
the creation of new courses at
additional medical schools; these
courses should be rigorously evaluated
and validated through peer review.
To our knowledge, the most organized
effort to move this agenda has been
through the Center for Medicine as a
Profession, which sponsors a grants
program supporting such curricular
development. A key component of
their initiative has been to create
dialogue among interested programs
and physicians. Perhaps this group
could serve as a nidus for a larger
conversation.
As we move forward toward the goals
stated above, we must keep in mind
their purpose. The practice of advocacy
should produce measurable outcomes
for patients and populations we serve
and help create a health system that is
more responsive to the health needs of
individuals and communities.
Mark A. Earnest, MD, PhD
Associate professor, Department of Medicine,
codirector, LEADS Program, and director of
interprofessional education, University of Colorado
Denver School of Medicine, Aurora, Colorado;
mark.earnest@ucdenver.edu.
Shale L. Wong, MD, MSPH
Associate professor of pediatrics, codirector, LEADS
program, and health policy fellow, Robert Wood
Johnson Foundation, University of Colorado Denver
School of Medicine, Aurora, Colorado.
Steven G. Federico, MD
Assistant professor of pediatrics and director of
school-based health centers, Denver Health,
University of Colorado Denver School of Medicine,
Aurora, Colorado.
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